SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry.

Saved in:
Bibliographic Details
Title: SUMOylation enhances DNMT1 function to repress mega-intergenic RNAs and viral mimicry.
Authors: Liddicoat BJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Balic JJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. jesse.balic@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. jesse.balic@petermac.org., Jia W; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Gillespie A; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Das AB; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Scolamiero L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Bediaga NG; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Chan YC; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., van der Maarel C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Guirguis AA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Prest K; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Sinclair OJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Talarmain L; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Litchfield C; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Lam EYN; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Hollizeck S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia., Horton JR; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kroeger B; Department of Anatomy and Developmental Biology, and Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Wang T; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA, USA., Zappacosta F; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA, USA., Annan RS; Medicinal Science and Technology, GlaxoSmithKline, Collegeville, PA, USA., Prinjha RK; GlaxoSmithKline R&D Stevenage, Stevenage, UK., Pappalardi MB; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., McCabe MT; Cancer Epigenetics Research Unit, Oncology, GlaxoSmithKline, Collegeville, PA, USA., Ang CS; Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia., Graus MS; The David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing, The Centenary Institute, The University of Sydney, Camperdown, New South Wales, Australia., Francois M; The David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing, The Centenary Institute, The University of Sydney, Camperdown, New South Wales, Australia., Harvey KF; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Anatomy and Developmental Biology, and Biomedicine Discovery Institute, Monash University, Melbourne, Victoria, Australia., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia., Cheng X; Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dawson MA; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.; The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australia. mark.dawson@petermac.org.
Source: Nature genetics [Nat Genet] 2026 Jul 21. Date of Electronic Publication: 2026 Jul 21.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1546-1718
DOI:10.1038/s41588-026-02664-1